Shakeri, Ahmad, and Christopher Adanty. 2020. “Romosozumab (sclerostin Monoclonal Antibody) for the Treatment of Osteoporosis in Postmenopausal Women: A Review”. Journal of Population Therapeutics and Clinical Pharmacology 27 (1): e25-e31. https://doi.org/10.15586/jptcp.v27i1.655.